15147-67-8 Usage
Uses
Used in Pharmaceutical Industry:
MSMPD is utilized as a key intermediate in the synthesis of nucleoside analogs, which are compounds that have shown potential as antiviral and anticancer drugs. The unique structure of MSMPD, including its methylsulfonyl and pentofuranosyl groups, contributes to the biological activities of the nucleoside analogs it helps to create.
1. Used in Antiviral Drug Development:
MSMPD is used as a building block for the development of antiviral agents. Its derivatives have demonstrated the ability to interfere with viral replication processes, making them valuable in the creation of new antiviral medications.
2. Used in Anticancer Drug Development:
MSMPD is also employed in the synthesis of compounds that target cancer cells. The resulting nucleoside analogs have shown promise in inhibiting the growth of cancer cells and may be further developed into effective anticancer treatments.
3. Used in Research and Development:
MSMPD and its derivatives are valuable for ongoing research aimed at understanding their biological activities and potential mechanisms of action. This research is crucial for the advancement of pharmaceuticals targeting viral and cancerous diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 15147-67-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,1,4 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 15147-67:
(7*1)+(6*5)+(5*1)+(4*4)+(3*7)+(2*6)+(1*7)=98
98 % 10 = 8
So 15147-67-8 is a valid CAS Registry Number.
15147-67-8Relevant academic research and scientific papers
Synthesis of novel 5'-uridine-head amphiphiles as model for DNA molecular recognition
Tiecco, Matteo,Di Profio, Pietro,Germani, Raimondo,Savelli, Gianfranco
experimental part, p. 911 - 923 (2010/09/04)
Here we describe uridine functionalization in the 5' position, which provides new classes of cationic and nonionic amphiphiles specifically designed as DNA transfection agents. The synthetic procedures developed to obtain the cationic uridine-head surfactants prevented intramolecular cyclization that occurs when uridine is functionalized in this position without using protecting groups in the uracil.
